Iovance Biotherapeutics Inc. (IOVA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
MHR Fund Management

Mark Rachesky

24,417,103 $81,308,953 9.77%
2.
Perceptive Advisors

Joseph Edelman

12,711,788 $42,330,254 -43% 1.49%
3. 9,250,055 $30,802,683 +81% 1.03%
4. 9,216,040 $30,689,413 +3% 0.52%
5. 7,785,000 $25,924,050 +19% 1.87%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.84 30,000 Officer 30,000 2025-06-05 Filing
$1.74 5,600 Officer 206,852 2025-05-23 Filing
$1.69 25,000 Officer, Director 374,646 2025-05-14 Filing
$9.15 250,000 Director 320,150 2024-02-20 Filing
$9.15 32,000 Director 54,000 2024-02-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$10.06 50,000 Director 7,500 2024-11-12 Filing
$8.71 20,500 Director 100,000 2016-08-25 Filing
$9.10 33,500 Director 120,500 2016-08-24 Filing
$9.11 54,000 Director 100,000 2016-08-22 Filing
$7.13 16,500 Director 154,000 2015-09-08 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 27,777,778 $92,500,000 0%
2. 24,314,578 $80,967,543 0%
3. 11,041,322 $36,767,602 0%
4. 5,968,298 $19,878,539 0%
5. 5,777,344 $19,238,556 0%
News See All